Notice of AGM

RNS Number : 8329A

Futura Medical PLC

26 March 2013

 



For immediate release

26 March 2013

Futura Medical plc

("Futura" or "the Company")

Notice of AGM

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that its AGM notice (including Explanatory Notes and Form of Proxy) has been posted to shareholders. The AGM will be held at 4pm on 7 May 2013.

Futura's annual report and accounts for the year ended 31 December 2012 is being made available to shareholders as an electronic communication pursuant to the Companies Act 2006 and is available at the Company's website www.futuramedical.com.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nominated Adviser: Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NOAUVOBROKAOUAR